1. Home
  2. NEON vs BCTX Comparison

NEON vs BCTX Comparison

Compare NEON & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

HOLD

Current Price

$0.89

Market Cap

27.5M

Sector

Technology

ML Signal

HOLD

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$3.50

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEON
BCTX
Founded
1997
2014
Country
Sweden
Canada
Employees
N/A
4
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.5M
26.6M
IPO Year
1994
2025

Fundamental Metrics

Financial Performance
Metric
NEON
BCTX
Price
$0.89
$3.50
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$40.00
AVG Volume (30 Days)
104.9K
127.0K
Earning Date
05-13-2026
06-15-2026
Dividend Yield
N/A
N/A
EPS Growth
37.88
N/A
EPS
N/A
N/A
Revenue
$3,108,000.00
N/A
Revenue This Year
$72.74
N/A
Revenue Next Year
$28.94
$380.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$0.63
52 Week High
$26.95
$14.68

Technical Indicators

Market Signals
Indicator
NEON
BCTX
Relative Strength Index (RSI) 52.40 49.70
Support Level $0.73 $2.98
Resistance Level $1.05 $4.51
Average True Range (ATR) 0.07 0.26
MACD 0.03 -0.04
Stochastic Oscillator 82.26 34.62

Price Performance

Historical Comparison
NEON
BCTX

About NEON Neonode Inc.

Neonode Inc provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. Its machine perception solutions are based on the MultiSensing technology platform. The company also offers optical sensing solutions for contactless touch and gesture sensing. It markets and sells its solutions mainly to customers in the automotive sector, along with other markets such as office equipment, industrial automation, medical, military, and avionics. Geographically, the company operates in Japan, South Korea, Germany, Sweden, China, and other regions, with a majority of its revenue generated from Japan.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: